Swiss Parenterals
Ticker > Company >

Swiss Parenterals share price

Swiss Parenterals Ltd.

SECTOR: Pharmaceuticals & Drugs  2.77 K   1   0

The company is currently not listed and is under IPO, so all the data might not be available.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year24.13%
3 Year85.45%
5 Year49.54%

Profit Growth

1 Year21.73%
3 Year136.17%
5 Year159.56%

ROE%

1 Year37.69%
3 Year37.28%
5 Year28.97%

ROCE %

1 Year48.99%
3 Year49.76%
5 Year38.54%

Debt/Equity

0.0051

Price to Cash Flow

0

Interest Cover Ratio

526.8636

CFO/PAT (5 Yr. Avg.)

0.995938792082906

 Strengths

  • The company has shown a good revenue growth of 85.4493728963307% for the Past 3 years.
  • The company has significantly decreased its debt by 18.65 Cr.
  • Company has been maintaining healthy ROE of 37.2785333333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 49.7563% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 526.8636.
  • The Company has been maintaining an effective average operating margins of 26.5969359950543% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of 31.4916 days.

 Limitations

 Looks like the company does not have any serious limitations.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2023 Mar 2024 Mar 2025
Net Sales 48.29 56.69 223.32 291.29 361.58
Total Expenditure 39.64 42.82 145.82 212.24 250.23
Operating Profit 8.65 13.87 77.5 79.05 111.35
Other Income 0.68 0.71 11.87 27.54 10.18
Interest 1.69 1.19 0.98 0.24 0.22
Depreciation 3.58 3.11 7.79 3.59 5.62
Exceptional Items 0 0 0 0 0
Profit Before Tax 4.06 10.28 80.59 102.76 115.69
Tax 1.43 3.81 21.5 32.82 30.55
Net Profit 2.63 6.46 59.09 69.94 85.14
Adjusted EPS (Rs.) 0 8.77 80.17 125.34 152.58

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 1.64 7.37 7.37 5.58 5.58
Total Reserves 25.43 26.21 264.71 177.84 262.79
Borrowings 5.89 6.15 0 0 0
Other N/C liabilities -0.17 -0.38 4.1 0.73 2.49
Current liabilities 17.33 28.21 63.31 141.54 133.72
Total Liabilities 50.12 67.57 339.49 325.69 404.58
Assets
Net Block 20.89 18.92 46.78 59.11 62.95
Capital WIP 0.32 4.21 1.81 0.21 11.71
Intangible WIP 0 0 0 0 0
Investments 0 0 15.38 5 0
Loans & Advances 0.5 3.08 25.67 32.43 128.15
Other N/C Assets 0 0.47 76.89 0.18 0
Current Assets 28.42 40.89 172.96 228.76 201.77
Total Assets 50.12 67.57 339.49 325.69 404.58
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2024 Mar 2025
Profit from operations 102.76 115.69
Adjustment -19.02 0.01
Changes in Assets & Liabilities 54.65 -3.14
Tax Paid -31.27 -21.54
Operating Cash Flow 107.12 91.02
Investing Cash Flow 32.13 -68.51
Financing Cash Flow -148.87 -19.04
Net Cash Flow -9.62 3.47

Corporate Actions

Company News

 No Latest News available for this company.Report us
Last Updated on:
Brief about Swiss Parenterals
X